Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional-comparative study.

Background: Androgenetic alopecia (AGA) is a common chronic dermatological illness that affects both men and women.

Aim: To assess and compare dermoscopically the impact of a combination of topical minoxidil solution (5%) and topical spironolactone solution (5%) in treating AGA in both sexes.

Patients And Methods: One hundred and twenty patients diagnosed with AGA were divided into three groups; each group is composed of 40 patients.